Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease

For the Dominantly Inherited Alzheimer Network Trials Unit

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences